OLN324

· Ollin Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OLN324, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 [Phase 1]

See pricing